'That's Huge, Folks': Amarin's Vascepa Cuts CV Risk By 25% On Top Of Statins

 
• By Mandy Jackson
Dart arrow hitting in the target center of dartboard using as background Target business, achieve and victory,success concept.

More from Clinical Trials

More from R&D